Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Celldex Therapeutics Inc

CLDX
Current price
35.38 USD -2.01 USD (-5.38%)
Last closed 36.92 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 2 433 415 424 USD
Yield for 12 month +13.47 %
1Y
3Y
5Y
10Y
15Y
CLDX
21.11.2021 - 28.11.2021

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey. Address: Perryville III Building, Hampton, NJ, United States, 08827

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

70.29 USD

P/E ratio

Dividend Yield

Current Year

+6 883 000 USD

Last Year

+2 357 000 USD

Current Quarter

+156 000 USD

Last Quarter

+4 131 000 USD

Current Year

+3 875 000 USD

Last Year

+957 000 USD

Current Quarter

-619 000 USD

Last Quarter

+3 372 000 USD

Key Figures CLDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -147 122 000 USD
Operating Margin TTM -26030.77 %
PE Ratio
Return On Assets TTM -15.73 %
PEG Ratio
Return On Equity TTM -25.39 %
Wall Street Target Price 70.29 USD
Revenue TTM 6 072 000 USD
Book Value 12.72 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -83.9 %
Dividend Yield
Gross Profit TTM -79 901 000 USD
Earnings per share -2.86 USD
Diluted Eps TTM -2.86 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CLDX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CLDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 11.02.2019
Dividend Date 11.02.2019

Stock Valuation CLDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 313.4705
Price Sales TTM 374.6439
Enterprise Value EBITDA -15.5186
Price Book MRQ 6.0085

Financials CLDX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CLDX

For 52 weeks

22.11 USD 53.18 USD
50 Day MA 39.69 USD
Shares Short Prior Month 6 989 589
200 Day MA 34.73 USD
Short Ratio 11.33
Shares Short 6 615 448
Short Percent 12.28 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.32 USD Microsoft Corporation +0.69 (+0.16%)
Detailed analytics

ETF funds


S

SX7EEX

14.75 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics